Called CanPathPro, the research consortium aims to combine omics data and systems biology tools into a single commercial platform for testing cancer hypotheses.
Iowa State geneticist Jeffrey Essner will lead a four-year, $3 million project to develop gene editing methods for animals in concert with ag-bio firm Recombinetics.
US National Institutes of Health will be examining its grant-awarding process for bias against African Americans, ScienceInsider reports.
The company said its new genetic variation analysis and visualization system will help provide clinicians with a more efficient way to make decisions about patient care.
University of Copenhagen researchers will examine the possibility of using next-generation sequencing to reconstruct the genomes of ancient and extinct species.
Researchers plan to develop a device that supports nucleic acid sequencing and protein sequencing using plasmonic nanostructures.
The VP lauded the work of the assembled researchers, offered suggestions for ways forward, and asked for their help in determining how to change the system for the better.
The center has invited experts to consider how technologies like CRISPR/Cas9 and mitochondrial replacement will affect values held by various groups.
As part of the effort, Virus.X also aims to craft new sequencing approaches, bioinformatics tools, and targeted gene products.
The Biotec Pharmacon subsidiary is taking part in the Virus-X EU Consortium by developing new viral enzymes and bringing them to the market.
A New Zealand minister says the country's genetic modification laws need to be re-examined to help combat climate change, the New Zealand Herald reports.
A new analysis finds some cancers receive more nonprofit dollars than others.
An Australian mother's conviction in the deaths of her children may be re-examined after finding that two of the children carried a cardiac arrhythmia-linked gene variant.
In Science this week: comparative analysis of sex differences in mammal gene expression, and more.